Kristof Deseure, Ph.D. - Publications

Affiliations: 
2005 Universiteit Antwerpen (Belgium) 
Area:
Medicine and Surgery, Pharmacology, Neuroscience Biology

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Deseure KR, Hans GH. Chronic Constriction Injury of the Distal Infraorbital Nerve (DIoN-CCI) in Mice to Study Trigeminal Neuropathic Pain. Journal of Visualized Experiments : Jove. PMID 38526120 DOI: 10.3791/66420  0.668
2018 Demartini C, Greco R, Zanaboni AM, Francesconi O, Nativi C, Tassorelli C, Deseure K. Antagonism of Transient Receptor Potential Ankyrin Type-1 Channels as a Potential Target for the Treatment of Trigeminal Neuropathic Pain: Study in an Animal Model. International Journal of Molecular Sciences. 19. PMID 30366396 DOI: 10.3390/Ijms19113320  0.51
2018 Deseure K, Hans G. Orofacial neuropathic pain reduces spontaneous burrowing behavior in rats. Physiology & Behavior. 191: 91-94. PMID 29673859 DOI: 10.1016/J.Physbeh.2018.04.020  0.684
2017 Deseure K, Hans G. Differential drug effects on spontaneous and evoked pain behavior in a model of trigeminal neuropathic pain Journal of Pain Research. 10: 279-286. PMID 28184169 DOI: 10.2147/Jpr.S124526  0.708
2016 Gris G, Portillo-Salido E, Aubel B, Darbaky Y, Deseure K, Vela JM, Merlos M, Zamanillo D. The selective sigma-1 receptor antagonist E-52862 attenuates neuropathic pain of different aetiology in rats. Scientific Reports. 6: 24591. PMID 27087602 DOI: 10.1038/Srep24591  0.522
2015 Deseure K, Hans GH. Chronic Constriction Injury of the Rat's Infraorbital Nerve (IoN-CCI) to Study Trigeminal Neuropathic Pain. Journal of Visualized Experiments : Jove. PMID 26437303 DOI: 10.3791/53167  0.7
2015 Deseure K, Hans G. Behavioral study of non-evoked orofacial pain following different types of infraorbital nerve injury in rats. Physiology & Behavior. 138: 292-6. PMID 25455862 DOI: 10.1016/J.Physbeh.2014.10.009  0.661
2013 Hans GH, Vandervliet E, Deseure K, Parizel PM. Cerebral activation during von Frey filament stimulation in subjects with endothelin-1-induced mechanical hyperalgesia: a functional MRI study. Biomed Research International. 2013: 610727. PMID 24151613 DOI: 10.1155/2013/610727  0.618
2012 Berquin A, Faymonville ME, Deseure K, Van-Liefferinge AS, Celentano J, Crombez G, Vlaeyen J, Hans G. Prise en charge de la douleur chronique non cancéreuse en Belgique: un état des lieux Douleur Et AnalgéSie. 25: 208-213. DOI: 10.1007/S11724-012-0307-7  0.56
2010 Fort M, Gris G, Aubel B, Vidal A, Romero L, González A, Portillo-Salido E, Darbaky Y, Deseure K, Vela J, Zamanillo D. 173 IN VIVO CHARACTERISATION OF THE NEW SELECTIVE SIGMA-1 RECEPTOR ANTAGONIST (S1RA): POTENTIAL USE FOR THE TREATMENT OF NEUROPATHIC PAIN European Journal of Pain Supplements. 4: 52-52. DOI: 10.1016/S1754-3207(10)70178-4  0.428
2009 Hans G, Deseure K, Vercauteren M. Altered sensitivity to mechanical stimulation during prolonged subcutaneous administration of endothelin-1 in rats. Journal of Pain Research. 2: 67-73. PMID 21197295 DOI: 10.2147/Jpr.S5529  0.658
2009 Portillo-Salido E, Nadal X, Sánchez-Arroyos R, Zamanillo D, Deseure K, Maldonado R, Vela J. 338 PHARMACOLOGICAL AND GENETIC EVIDENCE SUPPORTING THE POTENTIAL USEFULNESS OF BLOCKING SIGMA-1 RECEPTORS FOR THE TREATMENT OF NEUROPATHIC PAIN European Journal of Pain. 13: S103. DOI: 10.1016/S1090-3801(09)60341-4  0.42
2009 Gris G, Vidal A, Fort M, Aubel B, Romero L, González A, Portillo-Salido E, Baeyens J, Vela J, Deseure K, Zamanillo D. 335 ANALGESIC EFFICACY IN RAT MODELS OF EXPERIMENTAL PAIN OF A NEW SELECTIVE SIGMA-1 RECEPTOR ANTAGONIST European Journal of Pain. 13: S102b-S102. DOI: 10.1016/S1090-3801(09)60338-4  0.47
2008 Hans G, Deseure K, Adriaensen H. Endothelin-1-induced pain and hyperalgesia: a review of pathophysiology, clinical manifestations and future therapeutic options. Neuropeptides. 42: 119-32. PMID 18194815 DOI: 10.1016/J.Npep.2007.12.001  0.718
2007 Deseure K, Bréand S, Colpaert FC. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist. European Journal of Pharmacology. 568: 134-41. PMID 17512927 DOI: 10.1016/J.Ejphar.2007.04.022  0.408
2007 Hans G, Deseure K, Robert D, De Hert S. Neurosensory changes in a human model of endothelin-1 induced pain: a behavioral study. Neuroscience Letters. 418: 117-21. PMID 17403578 DOI: 10.1016/J.Neulet.2007.03.008  0.694
2007 Maldeghem K, Bruyneel P, Deseure K, Robert D, Hans G. 197 Application Of Lidocaine Patches 5%: How Many Patches Need To Be Applied On A Daily Base In Routine Clinical Practice? European Journal of Pain. 11: 85-86. DOI: 10.1016/J.Ejpain.2007.03.212  0.539
2006 Colpaert FC, Deseure K, Stinus L, Adriaensen H. High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning. The Journal of Pharmacology and Experimental Therapeutics. 316: 892-9. PMID 16254131 DOI: 10.1124/Jpet.105.095109  0.597
2006 Deseure K, Hans G. 208 SIGNS OF ALTERED NOCICEPTION AFTER PROLONGED ADMINISTRATION OF ENDOTHELIN-1 IN RATS European Journal of Pain. 10: S57a-S57. DOI: 10.1016/S1090-3801(06)60211-5  0.611
2004 Deseure KR, Adriaensen HF, Colpaert FC. Effects of the combined continuous administration of morphine and the high-efficacy 5-HT1A agonist, F 13640 in a rat model of trigeminal neuropathic pain. European Journal of Pain (London, England). 8: 547-54. PMID 15531223 DOI: 10.1016/j.ejpain.2004.01.002  0.554
2004 Deseure K, Adriaensen H. Nonevoked facial pain in rats following infraorbital nerve injury: a parametric analysis. Physiology & Behavior. 81: 595-604. PMID 15178152 DOI: 10.1016/J.Physbeh.2004.02.026  0.621
2003 Deseure K, Koek W, Adriaensen H, Colpaert FC. Continuous administration of the 5-hydroxytryptamine1A agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl]piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain. The Journal of Pharmacology and Experimental Therapeutics. 306: 505-14. PMID 12730352 DOI: 10.1124/jpet.103.050286  0.607
2002 Deseure K, Koek W, Colpaert FC, Adriaensen H. The 5-HT(1A) receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain. European Journal of Pharmacology. 456: 51-7. PMID 12450569 DOI: 10.1016/S0014-2999(02)02640-7  0.613
2002 Deseure KR, Adriaensen HF. Comparison between two types of behavioral variables of non-evoked facial pain after chronic constriction injury to the rat infraorbital nerve. Comparative Medicine. 52: 44-9. PMID 11900412  0.621
Show low-probability matches.